This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jul 21;380(9838):198-200.

doi: 10.1016/S0140-6736(12)60950-7. Epub 2012 Jun 18.

The long and short of antiarrhythmic drug treatment

A John Camm¹, Irene Savelieva

Affiliations

PMID: 22713625
DOI: 10.1016/S0140-6736(12)60950-7

Comment

The long and short of antiarrhythmic drug treatment

A John Camm et al. Lancet. 2012.

. 2012 Jul 21;380(9838):198-200.

doi: 10.1016/S0140-6736(12)60950-7. Epub 2012 Jun 18.

Authors

A John Camm¹, Irene Savelieva

Affiliation

¹ Department of Cardiological Sciences, St George's University of London, UK. jcamm@sgul.ac.uk

PMID: 22713625
DOI: 10.1016/S0140-6736(12)60950-7

No abstract available

PubMed Disclaimer

Comment on

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
Kirchhof P, Andresen D, Bosch R, Borggrefe M, Meinertz T, Parade U, Ravens U, Samol A, Steinbeck G, Treszl A, Wegscheider K, Breithardt G. Kirchhof P, et al. Lancet. 2012 Jul 21;380(9838):238-46. doi: 10.1016/S0140-6736(12)60570-4. Epub 2012 Jun 18. Lancet. 2012. PMID: 22713626 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information